Vice President, Corporate Communications

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone.  Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor.  Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”

Mineralys is a fully remote company.

Vice President, Corporate Communications

Position Overview

The Vice President, Corporate Communications is senior leadership role at Mineralys and is responsible for developing and executing Mineralys' comprehensive corporate communications strategy.

Mineralys is moving from a clinical-stage to a commercial-stage company. Commercial launch is a defining near-term milestone, but the mandate extends well beyond it: establishing a durable corporate narrative, building the internal communications infrastructure a growing organization requires, and positioning Mineralys with media,